Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on May 25, 2022 2:39pm
171 Views
Post# 34706998

RE:RE:RE:RE:RE:RE:Same old same old?

RE:RE:RE:RE:RE:RE:Same old same old?https://stockhouse.com/news/press-releases/2021/12/16/sirona-biochem-announces-engagement-of-pullan-consulting-to-close-optimal-deal 

But according to Howard's news release back in Dec the pharma they are dealing with is being transparent..... too bad SBM isn't taking note.

"Sirona is in the negotiation phase with a global top 10 pharmaceutical company for the rights to TFC-1067. Simultaneously, the company is completing the legal due diligence regarding contracts and patents, which is a straightforward task. The pharma company is advancing on the project as expected and has been transparent with next steps and timelines"

He's never going to change - not in his nature.  Time has shown this after repeated issues and stumbles and he just keeps on truck'n - rinse and repeat. 

At this point we need a professional like Linda @ Pullman Consulting to close a deal.  Hopefully Howard is letting her do more than "consult" otherwise it will be another wasted effort on SBM's part.  Hopefully Linda can pull a rabbit out of a hat land a fat lucrative contract and us long term SBM holders can finally exit stage left!  Wayyyyyyy overdue!  But hey here we are end of May and nothing, zippo, zilch - so I think it is going to be a long quiet Summer from SBM once again.  I'd love to be wrong - big time. 




<< Previous
Bullboard Posts
Next >>